Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response-Reference-Cited by-同舟云学术

Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response

Published:2013-04-16 Issue:5 Volume:62 Page:897-908
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Camisaschi Chiara,Filipazzi Paola,Tazzari Marcella,Casati Chiara,Beretta Valeria,Pilla Lorenzo,Patuzzo Roberto,Maurichi Andrea,Cova Agata,Maio Michele,Chiarion-Sileni Vanna,Tragni Gabrina,Santinami Mario,Vergani Barbara,Villa Antonello,Berti Emilio,Umansky Ludmila,Beckhove Philipp,Umansky Viktor,Parmiani Giorgio,Rivoltini Licia,Castelli Chiara

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s00262-013-1397-7/fulltext.html

Reference43 articles.

1. Campbell DJ, Koch MA (2011) Phenotypical and functional specialization of FOXP3 + regulatory T cells. Nat Rev Immunol 11:119–130

2. Viguier M, Lemaitre F, Verola O, Cho MS, Gorochov G, Dubertret L, Bachelez H, Kourilsky P, Ferradini L (2004) Foxp3 expressing CD4 + CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173:1444–1453

3. Curiel TJ (2008) Regulatory T cells and treatment of cancer. Curr Opin Immunol 20:241–246

4. Rech AJ, Vonderheide RH (2009) Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells. Ann N Y Acad Sci 1174:99–106

5. Ruter J, Barnett BG, Kryczek I, Brumlik MJ, Daniel BJ, Coukos G, Zou W, Curiel TJ (2009) Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines. Front Biosci 14:1761–1770

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal cancer: signaling pathways and advances in targeted therapies;MedComm;2024-08

2. A new frontier in cancer therapy: The intersection of cancer vaccines and metabolomics;Metabolomics for Personalized Vaccinology;2024

3. Self-assembled nanoparticles: A new platform for revolutionizing therapeutic cancer vaccines;Frontiers in Immunology;2023-02-21

4. The Nitrogen Mustards;Pharmacological Reviews;2022-06-16

5. Advancements of Common Gamma-Chain Family Cytokines in Cancer Immunotherapy;Immune Network;2022